Ascelia Pharma Announces Deputy CEO Julie Waras Brogren to Leave the Company

January 21, 2026 5:00 AM

Ascelia Pharma AB (publ) (STO:ACE) today announced that Deputy CEO Julie Waras Brogren will leave the company to take up a CEO position in another company.Julie Waras Brogren joined Ascelia Pharma in January 2020 as CCO and became Deputy CEO in October 2022. Since August 2023, she has also held the role of CFO.Magnus Corfitzen, CEO of Ascelia Pharma, said: "I want to thank Julie for her dedication to Ascelia Pharma. She has been instrumental in...

Read more

Senzime Secures Major Ivy League US Hospital System Contract

January 21, 2026 3:50 AM

Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured another strategic contract in the US with a leading Ivy League university hospital system. The contract includes in its first phase an installation of 60 next-generation TetraGraph systems, and annual usage from these monitors are expected to exceed 10,000 disposable sensors at full implementation."We are continuing to convert operating room after operating room with our...

Read more

iZafe Group Launches Modular Display and Remote Care System - One Dosell for All Users

January 21, 2026 3:15 AM

iZafe Group AB ("Company")(STO:IZAFE-B) today launches an external Display for Dosell together with a new remote care system featuring a web interface and mobile app. The launch takes place in connection with the MVTe trade fair, which starts today, where Dosell is exhibiting at booth I24. The new solution means that healthcare providers no longer need to choose between simpler or more advanced medication dispensing devices - the same Dosell can...

Read more

BioNxt Reports Final Preclinical Results Demonstrating Approximately 40% Higher Cladribine Delivery for the Treatment Multiple Sclerosis (MS)

January 21, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to report final results from a preclinical pig study demonstrating that its proprietary needle-free, swallow-free sublingual oral dissolvable film (ODF) cladribine formulation for the treatment of Multiple Sclerosis (MS) achieved significantly higher systemic drug delivery than a conventional oral tablet formulation of cladribine, such as those used in...

Read more

SoftWriters Strengthens Leadership Team with Addition of LiAna Tschen and Strategic Role Expansions

January 21, 2026 2:00 AM

SoftWriters, the leading provider of pharmacy management software for long-term care (LTC) pharmacies, today announced continued strategic investments to strengthen organizational depth and expand its platform and services. These investments are highlighted by the addition of LiAna Tschen as Vice President, Platform Operations, along with key leadership advancements that reinforce SoftWriters' commitment to innovation, operational excellence,...

Read more

Dispense Times Releases New Issue Featuring Mark Cuban, Offering Clarity for Independent Pharmacy Owners

January 21, 2026 12:00 AM

Dispense Times, a leading digital publication serving independent pharmacy owners across the United States, has released its latest January-February issue, featuring an in-depth article with Mark Cuban that helps clear up widespread misconceptions surrounding Cost Plus Drugs and its role within the pharmacy ecosystem.As conversations around alternative drug pricing models continue to gain attention, this issue was developed to provide pharmacy...

Read more

Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference

January 20, 2026 5:50 PM

Tivic Health® Systems, Inc. (NASDAQ:TIVC), a late-stage immunotherapeutics company, today announced that its CEO will provide a corporate update focused on recent developments in its advancement of Entolimod ™ during the Emerging Growth Virtual Conference on January 21 and 22, 2026WHO: Jennifer Ernst, Chief Executive OfficerWHERE: January 22, 2026WHEN: 4:10 - 4:20 Eastern TimeDuring the virtual conference update, Ms. Ernst will highlight recent...

Read more

Aytu BioPharma Recaps Investor Day Held on January 20, 2026

January 20, 2026 4:05 PM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today provided a summary of the Company's Investor Day, held today, Tuesday, January 20, 2026, at 11:00 a.m. Eastern time in New York City. The Investor Day was conducted both in-person and via webcast.A replay of the event can be...

Read more

Surgical Information Systems (SIS) Earns Eleventh Consecutive #1 Client Rating in Ambulatory Surgical Center IT User Satisfaction, Black Book 2026 Survey

January 20, 2026 3:15 PM

Black Book Research today announced that Surgical Information Systems (SIS) has again been rated #1 overall in Ambulatory Surgical Center (ASC) health IT user satisfaction-marking its eleventh consecutive year as the top-rated vendor in this category, based on validated end-user survey feedback.Client experience results from 1,130 ASC IT users including physicians, clinicians, and administrative staff ranked SIS first among ASC-focused...

Read more

Beyond Benign’s Green Chemistry Commitment Earns 2025 RSC Horizon Prize for Education for Advancing Green Chemistry in Higher Education

January 20, 2026 11:00 AM

Beyond Benign's Green Chemistry Commitment (GCC) has been awarded the Royal Society of Chemistry's 2025 Horizon Prize for Education, recognizing its innovative approach to advancing green chemistry in higher education. The prize celebrates the GCC's success in fostering a global community of practice that empowers educators to embed green chemistry into teaching, research, and institutional culture-preparing future scientists with the skills...

Read more

Saint Therese of Oxbow Lake Earns 2025 Zellner Group Client of the Year Award

January 20, 2026 10:10 AM

Senior living community Saint Therese of Oxbow Lake in Brooklyn Park has been named the 2025 Client of the Year by the Zellner Group, recognizing the community's outstanding partnership, leadership, and unwavering focus on resident-centered care. The Zellner Group is a senior health consulting firm that works with senior care organizations across Minnesota and western Wisconsin.The annual award honors one client organization that exemplifies...

Read more

Aytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA

January 20, 2026 9:00 AM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines to treat complex central nervous system disorders and improve the quality of life of patients, today announced the nationwide commercial launch of EXXUA and successful completion of its launch meeting last week that finalized sales training and launch preparations for EXXUA, the first and only selective 5-HT1A agonist...

Read more

Black Book Research Releases "New Zealand Acute Care EMR & Digital Health 2026" Companion Report

January 20, 2026 9:00 AM

Black Book Research announced today the availability of its new report, "New Zealand Acute Care EMR & Digital Health 2026: Companion Research Report: Demand Drivers, National Platforms, Standards and Vendor Landscape." The report is now available as a complimentary download for stakeholders across New Zealand and the Australia-New Zealand (ANZ) digital health...

Read more

Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office

January 20, 2026 8:05 AM

Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a science-driven leader in dermatologic solutions, today announced the Australian Patent Office has granted its patent application for its Spongilla technology combination as a method for treating acne. The patent, entitled "Compositions and methods for the treatment of skin conditions" (Australian Patent No. 2019419387), continues to strengthen Dermata's global...

Read more

Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Formulation of Alprazolam - Generic Xanax(R) - for Rapid Anxiety Relief

January 20, 2026 8:00 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced the filing of a new provisional patent application with the United States Patent and Trademark Office (USPTO). The application, titled "A Sublingual Powder Formulation of Alprazolam and Methods of Use Thereof," covers the first-ever sublingual powder formulation...

Read more

WellCheck Positions Its Health Equity Technology Platform as a Partner for Rural Health Systems Pursuing New Federal Funding

January 20, 2026 7:00 AM

As rural health systems across the United States prepare to pursue newly announced federal funding aimed at strengthening care delivery and access, WellCheck, a Baltimore-based health equity technology company, is reintroducing its platform as a trusted and proven solution designed to help rural communities connect services, close gaps in care, and demonstrate measurable impact.The Centers for Medicare & Medicaid Services (CMS) has committed $50...

Read more

Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection

January 20, 2026 6:00 AM

Moderna, Inc. (NASDAQ:MRNA) and Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced median five-year follow-up data from the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, evaluating intismeran autogene (mRNA-4157 or V940), an investigational mRNA-based individualized neoantigen therapy (INT), in combination with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in patients with high-risk melanoma (stage...

Read more

Ann Arbor Plastic Surgery Introduces Innovative Laser-Assisted Breast Augmentation for Enhanced Symmetry and Precision

January 19, 2026 12:55 PM

Ann Arbor Plastic Surgery, a leading cosmetic surgery practice in Michigan, is proud to highlight its advanced laser-assisted breast augmentation designed to deliver greater precision and symmetry in breast enhancement procedures. With this cutting-edge technique, the practice strives to set new standards in aesthetic breast surgery by combining surgical artistry with thoughtful technological innovation.Led by board-certified surgeons Dr. Pramit...

Read more

Desert Oasis Healthcare Supports Release of 7th Coachella Valley Community Health Survey, Advancing Data-Driven Community Impact

January 19, 2026 10:00 AM

Desert Oasis Healthcare (DOHC) is proud to support Health Assessment and Research for Communities (HARC) as it releases the 7th Coachella Valley Community Health Survey during a special community event at UC Riverside-Palm Desert on February 26th.The Coachella Valley Community Health Survey Data Release Event will showcase the latest survey findings, providing valuable insights into the health, well-being, and lived experiences of people across...

Read more

Curiteva Receives FDA Nano Designation for Inspire 3D Printed Trabecular PEEK Technology

January 19, 2026 8:00 AM

Curiteva, Inc., a leading privately held, technology-driven manufacturing company, announces the recent 510(k) clearance from the FDA for a nanotechnology designation for its Inspire 3D Printed Trabecular PEEK family of implants, featuring proprietary HAFUSE Surface Technology. This regulatory allowance highlights the implants' advanced physical and functional attributes, and advanced hydrophilicity, further strengthening the claims for the...

Read more